Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer

Pharmacogenetics

Volumn 9, Issue 3, 1999, Pages 333-340

  Wadelius, Mia ^a   Autrup, Judith L ^b   Stubbins, Michael J ^c,d   Andersson, Swen Olof ^e   Johansson, Jan Erik ^e   Wadelius, Claes ^a   Wolf, C Roland ^c   Autrup, Herman ^b   Rane, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

CYP; GSTP1; NAT2; Prostate cancer

Indexed keywords

ACYLTRANSFERASE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; STEROID HORMONE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; DENMARK; FAT INTAKE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SWEDEN;

EID: 0032798877     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199906000-00008     Document Type: Article

References (40)

1. Andersson S-O, Baron J, Bergström R, Lindgren C, Wolk A, Adami H-O. Life-style factors and prostate cancer risk - a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 1996; 5:509-513.
2. Brockmöller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydroxylase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996; 56:3915-3925.
3. Caporaso N, Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics 1995; 5:59-63.
4. Carter BS, Carter HB, Isaacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate 1990; 16:187-197.
5. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89:3367-3371.
6. Chen J, Stampfer MJ, Hough HL, Garcia-Closas M, Willett WC, Hennekens CH, et al. A prostective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998; 58:3307-3311.
7. Conney KA, McCarthy JD, Lange E, Huang L, Miesfeldt S, Montie JE, et al. Prostate cancer susceptibility locus on chromosome 1q. A confirmatory study. J Natl Cancer Inst 1997; 89:955-959.
8. Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 1991; 12:1197-1201.
9. Feigelson H, Ross RK, Yu MC, Coetzee GA, Reichardt JKV, Henderson BE. Genetic susceptibility to cancer from exogenous and endogenous exposures. J Cell Biochem 1996; 25S:15-22.
10. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci E, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994; 86:281-286.
11. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85:1571-1579.
12. Grönberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. A nation-wide register cohort study. Cancer 1996a; 77:138-143.
13. Grönberg H, Damber L, Damber JE. Total food consumption and body mass index in relation to prostate cancer risk. A case-control study in Sweden with prospectively collected exposure data. J Urol 1996b; 155:969-974.
14. Guengerich FP. Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. Am J Clin Nutr 1995; 61:651S-658S.
15. Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644.
16. Hein DW, Rustan TD, Bucher KD, Furman EJ, Martin WJ. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J Pharmacol Exp Ther 1991; 258:232-236.
17. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA 1998; 95:5275-5280.
18. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996; 7:83-94.
19. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, et al. Cytidine methylation of regulatory sequences near the Pi class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994; 91:11733-11737.
20. Lumey LH, Pittman B, Zang EA, Wynder EL. Cigarette smoking and prostate cancer: no relation with six measures of lifetime smoking habits in a large case-control study among US whites. Prostate 1997; 33:195-200.
21. de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 1994; 269:15419-15422.
22. Muiras ML, Verasdonck P, Cottet, F, Schächter F. Lack of association between human longevity and genetic polymorphisms in drug metabolizing enzymes at the NAT2, GSTM1 and CYP2D6 loci. Hum Genet 1998; 102:526-532.
23. Nagao M, Sigamura T. Carcinogenic factors in food with relevance to colon cancer development. Mutat Res 1993; 290:43-51.
24. Okkels H, Sigsgaard T, Wolf H, Autrup H. Arylamine N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer. The influence of smoking. Cancer Epidemiol Biomarkers Prev 1997; 6:225-231.
25. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1993; 118:793-803.
26. Porter TD, Coon MJ. Cytochrome P450. Multiplicity of isoforms, substrates and catalytic and regulatory mechanisms. J Biol Chem 1991; 266:13469-13472.
27. Risch A, Wallace DMA, Bathers S, Sim E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 1995; 4:231-236.
28. Ross RK. Epidemiology of prostate cancer and bladder cancer: an overview. Cancer Treat Res 1996; 88:1-11.
29. Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 1994; 86:252-254.
30. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997; 57:195-198.
31. Smith CAD, Moss JE, Gough AC, Spurr NK, Wolf CR. Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility. Environ Health Persp 1992a; 98:107-112.
32. Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE. Maranganore DM, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992b; 339:1375-1379.
33. Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274:1371-1373.
34. Smith CAD, Wadelius M, Gough AC, Wolf RC, Rane A. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J Med Genet 1997; 34:758-760.
35. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, Jernström B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19:433-436.
36. Swedish Cancer Registry. Centre for Epidemiology, National Board of Health and Welfare. Cancer Incidence in Sweden 1996. Stockholm: Norskdts tryckeri AB, 1998
37. Welfare MR, Cooper J, Bassendine MF, Daly AK. Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England. Carcinogenesis 1997; 18:1351-1354.
38. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995; 141:732-740.
39. Wolf CR, Smith CAD, Gough AC, Moss JE, Vallis KA, Howard G, et al. Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis 1992; 13:1035-1038.
40. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem 1994; 224:893-899.